Aspen Pharmacare Holdings (APN.JO) Osake Kurssi

Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.

The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.

Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.

Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.

Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.

Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.

Analyytikot asettavat tällä hetkellä Aspen Pharmacare Holdings-osakkeelle keskimääräisen tavoitehinnan 120,02 ZAR (mediaani: 117,30 ZAR), mikä merkitsee −27,0 % viimeisimpään hintaan verrattuna. Konsensus perustuu 10 analyytikkoarvioon.

Aspen Pharmacare Holdings Analyytikkojen kursstavoitteet 2026

10 analyytikkoa arvioi tällä hetkellä Aspen Pharmacare Holdings-osaketta: 0 suosittaa ostoa, 6 pitoa ja 4 myyntiä.

Aspen Pharmacare Holdings Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla Aspen Pharmacare Holdings-osake noteerataan hintaan 8,84 EUR (164,45 ZAR).

Aspen Pharmacare Holdings-osake (APN.JO) on listattuna 5 pörssissä, muun muassa: JSE (Johannesburg) (APN.JO), Frankfurt (LDZA.F), München (LDZA.MU), Düsseldorf (LDZA.DU).

Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.

liikevaihto Aspen Pharmacare Holdings on 34,87 Mrd. ZAR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

voitto Aspen Pharmacare Holdings on 2,65 Mrd. ZAR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Aspen Pharmacare Holdings:n hinta-voitto-suhde (P/E) on tällä hetkellä 27,55. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Aspen Pharmacare Holdings-osakkeen arvostusta.

Aspen Pharmacare Holdings:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,09. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Aspen Pharmacare Holdings-osakkeen arvostuskennuslukuna.

Aspen Pharmacare Holdings:n Eulpool-laatuscore on 1/10.

Aspen Pharmacare Holdings:n ISIN on ZAE000066692. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Aspen Pharmacare Holdings:n WKN on A0ET80. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Aspen Pharmacare Holdings:n ticker on APN.JO. Tämä pörssinoteeraus käytetään Aspen Pharmacare Holdings-osakkeiden kauppaan pörssissä.